Jefferies names Sai Life, Divi's, and Cohance as top Indian CRDMO picks with up to 37% upside—see which pharma stocks to watch now!

We live in a world where $1 billion of prescription medications are left at the pharmacy counter each year, often because ...

Serena Williams recently shared that she started taking the GLP-1 drug Zepbound after having her two children. The tennis ...

Galectin's belapectin shows promise in MASH cirrhosis despite setbacks. High-risk investment with upcoming FDA meeting ...

The mad rush for safe and effective obesity drugs has winners—including Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy—and ...

Tirzepatide has been shown to be effective in OSA, but evidence related to comorbid insomnia and sleep apnea (COMISA) is lacking.

Citigroup recommends buying Divis Laboratories, citing reasonable valuations and sector tailwinds. JP Morgan maintains an ...

COMMENT: Weight-loss drugs for dogs are the next big thing in pet healthcare. It’s no bad thing, says Charlotte Cripps, who ...

Meghan Trainor participated in the viral Nicki Minaj TikTok Challenge, and she quickly faced a flood of comments from users ...